Journal de Mycologie Medicale

Papers
(The TQCC of Journal de Mycologie Medicale is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Invasive fungal diseases during COVID-19: We should be prepared231
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature79
Mucormycosis treatment: Recommendations, latest advances, and perspectives70
Treatment and management strategies of onychomycosis48
Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates32
Critically ill patients with COVID-19 and candidaemia: We must keep this in mind24
First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus21
Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report19
Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy19
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus17
Antifungal activity of endophytic fungi from Cupressaceae against human pathogenic Aspergillus fumigatus and Aspergillus niger17
Candida africana vulvovaginitis: Prevalence and geographical distribution16
Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population16
Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species15
Overview about Candida auris: What's up 12 years after its first description?15
Earliest case of Candida auris infection imported in 2007 in Europe from India prior to the 2009 description in Japan15
Trichophyton indotineae, from epidemiology to therapeutic14
High colonization by Candida parapsilosis sensu stricto on hands and surfaces in an adult intensive care unit14
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review14
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis13
Aspergillus peritonitis in peritoneal dialysis patients: A systematic review13
Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort13
Mortality and risk factor analysis for Candida blood stream infection: A three-year retrospective study12
Ketoconazole-loaded poly-(lactic acid) nanoparticles: Characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes12
Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia12
COVID-19 and Candida duobushaemulonii superinfection: A case report12
Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary12
Anti-Candida activity of the water-soluble lectin from Moringa oleifera seeds (WSMoL)11
Preparation, characterization and antidermatophytic activity of free- and microencapsulated cinnamon essential oil11
The effectiveness of surface disinfectants and a micellic H2O2 based water disinfectant on Candida auris11
Isolation and characterization of ergosterol from Monascus anka for anti-lipid peroxidation properties11
Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes – a tertiary care center experience11
COVID-19 and invasive fungal coinfections: A case series at a Brazilian referral hospital10
Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality10
Estimates of serious fungal infection burden in Côte d’Ivoire and country health profile10
Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature9
Mucormycosis: A killer in the shadow of COVID-199
Physiological characterization and molecular identification of some rare yeast species causing onychomycosis8
Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia8
In vitro antifungal and antibiofilm activities of novel sulfonyl hydrazone derivatives against Candida spp.8
Identification of Malassezia species isolated from some Malassezia associated skin diseases8
Black aspergilli as causes of otomycosis in the era of molecular diagnostics, a mini-review8
Anticandidal and synergistic effect of essential oil fractions from three aromatic plants used in Cameroon8
Determination of dermatophytes isolated from tinea capitis using conventional and ITS-based sequencing methods in Kano, Nigeria.8
Invasive rhino-orbital-cerebral aspergillosis in an immunocompetent patient8
Cryptococcosis in HIV-AIDS patients from Southern Brazil: Still a major problem8
Essential oils and their components in combating fungal pathogens of animal and human skin8
Can the essential oil of rosemary (Rosmarinus officinalis Linn.) protect rats infected with itraconazole-resistant Sporothrix brasiliensis from fungal spread?7
Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature7
Coronavirus disease and candidemia infection: A case report7
Human sporotrichosis outbreak caused by Sporothrix brasiliensis in a veterinary hospital in Southern Brazil7
A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa7
Candida nivariensis: Identification strategy in mycological laboratories7
Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy7
Pythiosis in cats in northeastern Brazil7
Kazachstania slooffiae: An unexpected journey to a human pleural sample7
COVID-19-associated mucormycosis in India: Why such an outbreak?7
Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period6
Apophysomyces variabilis, an emerging and worrisome cause of primary cutaneous necrotizing infections in India6
Activity of MSI-78, h-Lf1-11 and cecropin B antimicrobial peptides alone and in combination with voriconazole and amphotericin B against clinical isolates of Fusarium solani6
Antifungal susceptibility of oral isolates of Candida species from chronic kidney disease patients on chronic dialysis6
Carnosol inhibits the growth and biofilm of Candida albicans6
Multidrug resistant tinea corporis/cruris: Response to voriconazole6
Species distribution and antifungal susceptibility patterns of clinical Candida isolates in North Lebanon: A pilot cross-sectional multicentric study6
Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex6
Antifungal sensitivity and species of yeasts in oral mucosa of street mixed-breed dogs6
Review: Emergomycosis6
Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus6
Simulated vaginal fluid: Candida resistant strains’ biofilm characterization and vapor phase of essential oil effect6
Diversity of Fusarium species causing invasive and disseminated infections6
Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples6
Otomycosis in Africa: Epidemiology, diagnosis and treatment6
Photodynamic therapy-mediated hypericin-loaded nanostructured lipid carriers against vulvovaginal candidiasis6
Tinea capitis at the University Hospital of Tizi-Ouzou, Algeria, and first isolation of Trichophyton tonsurans6
Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study6
Survival of an immuno-competent patient from splenic and gastric mucormycosis-case report and review of the literature6
Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap6
Tuberculosis and neurocryptococcosis by Cryptococcus neoformans molecular type VNI in A non-HIV patient: A comorbidities case report5
Epidemiology of Pityriasis versicolor in Tunisia: Clinical features and characterization of Malassezia species5
Dermatophytosis caused by Nannizzia nana5
Keystone salivary mycobiome in postpartum period in health and disease conditions5
Review on host-pathogen interaction in dermatophyte infections5
Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review5
Adhesion of Candida tropicalis to polystyrene and epithelial cell lines: Insights of correlation of the extent of adherent yeast cells among distinct surfaces5
Mucormycosis in COVID-19: The Indian scenario5
Disseminated histoplasmosis diagnosed by cross-reactivity with the Aspergillus galactomannan antigen in an HIV-positive patient5
The challenge of access to refined fungal diagnosis: An investment case for low- and middle-income countries5
Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study5
Clinical profile, antifungal susceptibility, and molecular characterization of Candida auris isolated from patients in a South Indian surgical ICU.5
Efficacy and safety of echinocandin monotherapy and combination therapy for immunocompromised patients with systemic candidiasis: A systematic review and meta-analysis5
Predisposing factors, clinical features and treatment outcomes of Fusarium onychomycosis and comparison of its characteristics with Neoscytalidium onychomycosis5
Papiliotrema laurentii fungemia in a premature, very low-birth-weight neonate in Kuwait successfully treated with liposomal amphotericin B5
0.030103921890259